Last reviewed · How we verify

Noxibiol (NITROXOLINE)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic nameNITROXOLINE
Drug classnitroxoline
TargetBromodomain-containing protein 4, Cathepsin B, Cystathionine gamma-lyase
ModalitySmall molecule
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: